Biotech stocks have been on fire this weekBoth ProShares Ultra Nasdaq Biotechnology (BIB) and the iShares Nasdaq Biotechnology ETF (IBB) are heading for new 2017 highs as the month comes to a closeAmong the top gainers, along with Biogen (BIIB) , Gilead (GILD) and Amgen (AMGN) , is Illumina (ILMN) . Today's breakout move in the stock has driven sh...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.